Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans
Authors not listed
National Institute on Aging (NIA) · 2021
Abstract
Background:
The immune response is how the body recognizes and defends itself against foreign and harmful substances. Researchers want to compare the immune responses between young and older healthy adults after they receive vaccine doses for COVID-19. This research may help to determine whether age impacts cell response to COVID-19 vaccines.
Objective:
To study the immune response of people who receive Pizer or Moderna COVID-19 vaccines.
Eligibility:
People aged 18 and older who have not had COVID-19 and who either plan to receive the first dose of a COVID-19 vaccine within the next month or have received at least the first of 2 doses of the vaccine within the last 6 months.
Design:
Participants will be screened by telephone.
Participants will not get the COVID-19 vaccine in this study. They must get it through a vaccine location.
Participants who have not yet been vaccinated will have 7 visits. The first 4 visits will occur in the first month before and after each vaccination. The last 3 visits will occur 6 months, 1 year, and 2 years after completed vaccination.
Participants who have received at least 1 of 2 doses of the COVID-19 vaccine within the last 6 months will have 3 visits. The first visit will occur within 6 months of receiving the first vaccine dose. The last 2 visits will occur 1 year and 2 years after the first vaccine dose.
At visits, participant will review their medical history. Their height, weight, and/or vital signs will be measured. They will give blood samples after fasting. They may give urine samples. They may have a nasal swab test for COVID-19.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Anonymous. (2021). A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans. <em>National Institute on Aging (NIA)</em>. https://clinicaltrials.gov/study/NCT04852289
Vancouver
Anonymous. A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans. National Institute on Aging (NIA). 2021.
BibTeX
@misc{anon2021AClini,
title = {A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans},
author = {Anonymous},
journal = {National Institute on Aging (NIA)},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Vanderbilt University 2010
Open access · US-GOV
Evaluation of Cell-mediated Immunity and Antibody Response to Influenza Vaccination and Correlates of Protection in Seniors
National Institute on Aging (NIA) 2016
Open access · US-GOV
A Pilot Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing
National Institute on Aging (NIA) 2012
Open access · US-GOV
Assessing Mechanisms Accounting for Unexplained Anemia in the Elderly
National Institute of Neurological Disorders and Stroke (NINDS) 2018
Open access · US-GOV
Influence of Brain Oscillation-Dependent TMS on Motor Function
The Jackson Laboratory 2017
Open access · US-GOV
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
National Institute on Aging (NIA) 2015
Open access · US-GOV